Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342)

OBJECTIVES: The multinational PEARLS (ACTG A5175) study, conducted mainly in resource-limited settings, identified an increased treatment failure rate among HIV-infected individuals randomized to once-daily unboosted atazanavir, didanosine-EC, and emtricitabine compared with efavirenz-based regimens...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Antimicrob Chemother
Main Authors: Castillo-Mancilla, Jose R., Aquilante, Christina L., Wempe, Michael F., Smeaton, Laura M., Firnhaber, Cynthia, LaRosa, Alberto M., Kumarasamy, Nagalingeswaran, Andrade, Adriana, Baheti, Gautam, Fletcher, Courtney V., Campbell, Thomas B., Haas, David W., MaWhinney, Samantha, Anderson, Peter L.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4867099/
https://ncbi.nlm.nih.gov/pubmed/26892777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados